Create Account | Sign In: Author or Forum

Search Symptoms


ACC: Icosapent Ethyl Beneficial for Statin-Treated Patients

March 19, 2019. 12:00 PM CDT. Risk for ischemic events lower for patients with elevated triglycerides and atherosclerosis or diabetes Read article


AAD: Isotretinoin Exposure for Acne Not Linked to Depression Risk

March 01, 2019 Acne patients with, without isotretinoin exposure had no significant difference in depression frequency

Darolutamide Slows Spread of Castration-Resistant Prostate Cancer

February 19, 2019 Significant survival benefit seen, adverse events similar between darolutamide and placebo

ASA: Intensive BP Control Lowers Bleeding Risk in Stroke Patients

February 12, 2019 Findings seen among patients with ischemic stroke, high systolic BP receiving alteplase for thrombolysis

ASA: Opioid Epidemic Tied to Infection-Related Stroke

February 12, 2019 Number of hospitalizations steady in 1993 to 2008, but increased significantly in 2008 to 2015

ASA: Reversal Agent Cuts Severe Bleeding With Factor Xa Inhibitors

February 11, 2019 Bolus plus two-hour infusion of andexanet alfa cuts antifactor Xa activity by 92 percent

Reproductive Health Counseling Inadequate in IBD

February 11, 2019 Only 30 percent of patients reported prior counseling; most interested in receiving more information

SABCS: Low-Dose Tamoxifen Cuts Risk for Breast Dz

December 06, 2018 More second primary cancers and more frequent menopausal symptoms seen in tamoxifen vs. placebo arm

SABCS: Delaying Chemo Lowers Survival in Triple-Neg Breast CA

December 05, 2018 Findings show delaying chemo over 30 days postsurgery lowers triple-negative breast cancer survival

ASH: Rivaroxaban Prevents Blood Clots in At-Risk Cancer Patients

December 05, 2018 Risk for patients in rivaroxaban group reduced during the on-treatment period

ASH: A+CHP Bests CHOP for Peripheral T-Cell Lymphoma

December 05, 2018 Median progression-free survival improved with A+CHP vs CHOP; similar incidence of adverse events

SABCS: T-DM1 Cuts Recurrent Invasive HER2+ Breast CA Risk

December 05, 2018 Risk reduced with trastuzumab emtansine in those with residual invasive dz at sx after neoadjuvant chemo

ASH: Ibrutinib Tops Bendamustine + Rituximab for CLL

December 03, 2018 Improved progression-free survival with ibrutinib for older adults with untreated CLL

ASH: High Response to Tx After Checkpoint Blockade in NHL, HL

December 03, 2018 Immunotherapy boosts later therapy for relapsed, refractory non-Hodgkin, Hodgkin lymphoma

Immunotherapy Side Effects May Be More Common Than Thought

November 20, 2018 Higher rates of adverse events observed for immune checkpoint inhibitors in real-world settings

ACAAI: Oral Immunotherapy Is Protective in Peanut Allergy

November 19, 2018 More patients receiving AR101 able to ingest ≥600 mg peanut protein without dose-limiting symptoms